Skip to content

Redicare Redisplint Conforming Splint

by Redicare LLC

Redicare Redisplint Conforming Splint (0305006) is a first aid limb splint (FDA Class I; FDA product code NOC, Splint, Extremity, Non-Inflatable, External, Non-Sterile) made by Redicare LLC, listed in FDA GUDID since 28 Jul 2020 (UDI-DI B70903050060), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB70903050060 UDI-DI Date28 Jul 2020ListedStatusListed GUDID: in commercial distribution

From the FDA record

Device description
4.25" x 24" Padded Aluminum Conforming Splint
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Redicare
Generic name
First aid limb splint, mouldable, single-use
Model / Ref / Catalog
Redisplint Conforming Splint, 0305006
Primary DI / UDI-DI
B70903050060
FDA product code
NOC
GMDN term
First aid limb splint, mouldable, single-use
Device class
Class I
Regulation number
878.3910
GUDID distribution status
In Commercial Distribution
Size
Width — 4.25 Inch
Length — 24 Inch

Similar devices

Other devices filed under FDA product code NOC (Splint, Extremity, Non-Inflatable, External, Non-Sterile).

Other devices from Redicare LLC

See all devices from Redicare LLC →

Properties

  • Single use
  • Over-the-counter
  • Premarket exempt
  • Lot / batch number
Other properties (11, all answered No)